Examination of oral cancer biomarkers by tissue microarray analysis

Archives of Otolaryngology - Head and Neck Surgery

Volumn 134, Issue 5, 2008, Pages 539-546

  Choi, Peter ^a   Jordan, C Diana ^b   Mendez, Eduardo ^a,c   Houck, John ^d   Yueh, Bevan ^e   Farwell, D Gregory ^f   Futran, Neal ^a   Chen, Chu ^a,b,d  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; OSTEONECTIN; PROTEIN CDH11; PROTEIN DERIVATIVE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN TGM3; PROTEIN TNC; STROMELYSIN; TENASCIN; TRANSCRIPTION FACTOR RUNX2;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; KERATINOCYTE; MALE; MICROARRAY ANALYSIS; MOUTH CARCINOMA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; STROMA; TISSUE MICROARRAY;

CADHERINS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; CELLS, CULTURED; HUMANS; IMMUNOHISTOCHEMISTRY; LINEAR MODELS; MATRIX METALLOPROTEINASE 3; MOUTH NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEONECTIN; REPRODUCIBILITY OF RESULTS; TENASCIN; TISSUE ARRAY ANALYSIS; TRANSGLUTAMINASES; TUMOR MARKERS, BIOLOGICAL;

EID: 44249127934     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.134.5.539     Document Type: Article

References (46)

1. Sankaranarayanan R, Masuyer E, Swaminathan R, Ferlay J, Whelan S. Head and neck cancer: a global perspective on epidemiology and prognosis. Anticancer Res. 1998;18(6B):4779-4786.
2. Ries LAG, Harkins D, Krapcho M, et al. SEER Cancer Statistics, Review 1975-2003. Bethesda, MD: National Cancer Institute; 2006.
3. Genden EM, Ferlito A, Bradley PJ, Rinaldo A, Scully C. Neck disease and distant metastases. Oral Oncol. 2003;39(3):207-212.
4. Dimery IW, Hong WK. Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst. 1993;85(2):95-111.
5. Choi P, Chen C. Genetic expression profiles and biologic pathway alterations in head and neck squamous cell carcinoma. Cancer. 2005;104(6):1113-1128.
6. Okazaki M, Takeshita S, Kawai S, et al. Molecular cloning and characterization of OB-cadherin, a new member of cadherin family expressed in osteoblasts. J Biol Chem. 1994;269(16):12092-12098.
7. Wiegand S, Dunne AA, Muller HH, et al. Meta-analysis of the significance of matrix metalloproteinases for lymph node disease in patients with head and neck squamous cell carcinoma. Cancer. 2005;104(1):94-100.
8. Bradshaw AD, Graves DC, Motamed K, Sage EH. SPARC-null mice exhibit increased adiposity without significant differences in overall body weight. Proc Natl Acad Sci U S A. 2003;100(10):6045-6050.
9. Chin D, Boyle GM, Williams RM, et al. Novel markers for poor prognosis in head and neck cancer. Int J Cancer. 2005;113(5):789-797.
10. 5 integrins and promotes cell motility. Cancer Res. 2002;62(18):5358-5364.
11. Kudo Y, Ogawa I, Kitajima S, et al. Periostin promotes invasion and anchorage-independent growth in the metastatic process of head and neck cancer. Cancer Res. 2006;66(14):6928-6935.
12. Siriwardena BS, Kudo Y, Ogawa I, et al. Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancer. Br J Cancer. 2006;95(10):1396-1403.
13. Jones FS, Jones PL. The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling. Dev Dyn. 2000;218(2):235-259.
14. Kim IG, Gorman JJ, Park SC, Chung SI, Steinert PM. The deduced sequence of the novel protransglutaminase E (TGase3) of human and mouse. J Biol Chem. 1993;268(17):12682-12691.
15. Hitomi K, Presland RB, Nakayama T, Fleckman P, Dale BA, Maki M. Analysis of epidermal-type transglutaminase (transglutaminase 3) in human stratified epithelia and cultured keratinocytes using monoclonal antibodies. J Dermatol Sci. 2003;32(2):95-103.
16. Luo A, Kong J, Hu G, et al. Discovery of Ca2+-relevant and differentiation-associated genes downregulated in esophageal squamous cell carcinoma using cDNA microarray. Oncogene. 2004;23(6):1291-1299.
17. Liu W, Yu ZC, Cao WF, Ding F, Liu ZH. Functional studies of a novel oncogene TGM3 in human esophageal squamous cell carcinoma. World J Gastroenterol. 2006;12(24):3929-3932.
18. Chen BS, Wang MR, Xu X, et al. Transglutaminase-3, an esophageal cancer-related gene. Int J Cancer. 2000;88(6):862-865.
19. Ohkura S, Kondoh N, Hada A, et al. Differential expression of the keratin-4, -13, -14, -17 and transglutaminase 3 genes during the development of oral squamous cell carcinoma from leukoplakia. Oral Oncol. 2005;41(6):607-613.
20. Méndez E, Cheng C, Farwell DG, et al. Transcriptional expression profiles of oral squamous cell carcinomas. Cancer. 2002;95(7):1482-1494.
21. Budwit-Novotny DA, McCarty KS, Cox EB, et al. Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Res. 1986;46(10):5419-5425.
22. Zidar N, Gale N, Kambic V, Fischinger J. Expression of tenascin and fibronectin in benign epithelial hyperplastic lesions and squamous carcinoma of the larynx. Anticancer Res. 2001;21(1A):451-454.
23. Juhász A, Bardos H, Repassy G, Adany R. Characteristic distribution patterns of tenascin in laryngeal and hypopharyngeal cancers. Laryngoscope. 2000;110(1):84-92.
24. Hindermann W, Berndt A, Borsi L, et al. Synthesis and protein distribution of the unspliced large tenascin-C isoform in oral squamous cell carcinoma. J Pathol. 1999;189(4):475-480.
25. Regezi JA, Ramos DM, Pytela R, Dekker NP, Jordan RC. Tenascin and β6 integrin are overexpressed in floor of mouth in situ carcinomas and invasive squamous cell carcinomas. Oral Oncol. 2002;38(4):332-336.
26. Dang C, Gottschling M, Roewert J, Forschner T, Stockfleth E, Nindl I. Tenascin-C patterns and splice variants in actinic keratosis and cutaneous squamous cell carcinoma. Br J Dermatol. 2006;155(4):763-770.
27. Chiquet-Ehrismann R, Chiquet M. Tenascins: regulation and putative functions during pathological stress. J Pathol. 2003;200(4):488-499.
28. Roepman P, Wessels LF, Kettelarij N, et al. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet. 2005;37(2):182-186.
29. Schmalbach CE, Chepeha DB, Giordano TJ, et al. Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2004;130(3):295-302.
30. O'Donnell RK, Kupferman M, Wei SJ, et al. Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity. Oncogene. 2005;24(7):1244-1251.
31. Marcus B, Arenberg D, Lee J, et al. Prognostic factors in oral cavity and oropharyngeal squamous cell carcinoma. Cancer. 2004;101(12):2779-2787.
32. Reichert TE, Scheuer C, Day R, Wagner W, Whiteside TL. The number of intratumoral dendritic cells and ζ-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma. Cancer. 2001;91(11):2136-2147.
33. Badoual C, Hans S, Rodriguez J, et al. Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers. Clin Cancer Res. 2006;12(2):465-472.
34. Pawelec G. Tumour escape: antitumour effectors too much of a good thing? Cancer Immunol Immunother. 2004;53(3):262-274.
35. Jeon GA, Lee JS, Patel V, et al. Global gene expression profiles of human head and neck squamous carcinoma cell lines. Int J Cancer. 2004;112(2):249-258.
36. Moriya T, Seki N, Shimada K, et al. In-house cDNA microarray analysis of gene expression profiles involved in SCC cell lines. Int J Mol Med. 2003;12(4):429-435.
37. Irié T, Aida T, Tachikawa T. Gene expression profiling of oral squamous cell carcinoma using laser microdissection and cDNA microarray. Med Electron Microsc. 2004;37(2):89-96.
38. Leethanakul C, Patel V, Gillespie J, et al. Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays. Oncogene. 2000;19(28):3220-3224.
39. Leethanakul C, Knezevic V, Patel V, et al. Gene discovery in oral squamous cell carcinoma through the Head and Neck Cancer Genome Anatomy Project: confirmation by microarray analysis. Oral Oncol. 2003;39(3):248-258.
40. Hwang D, Alevizos I, Schmitt WA, et al. Genomic dissection for characterization of cancerous oral epithelium tissues using transcription profiling. Oral Oncol. 2003;39(3):259-268.
41. Paget S. The distribution of secondary growths in cancer of the breast. Lancet. 1889;1:571-573.
42. Mueller MM, Fusenig NE. Friends or foes: bipolar effects of the tumour stroma in cancer. Nat Rev Cancer. 2004;4(11):839-849.
43. Rosenthal EL, McCrory A, Talbert M, Carroll W, Magnuson JS, Peters GE. Expression of proteolytic enzymes in head and neck cancer-associated fibroblasts. Arch Otolaryngol Head Neck Surg. 2004;130(8):943-947.
44. Rosenthal E, McCrory A, Talbert M, Young G, Murphy-Ullrich J, Gladson C. Elevated expression of TGF-β1 in head and neck cancer-associated fibroblasts. Mol Carcinog. 2004;40(2):116-121.
45. Ziober AF, Falls EM, Ziober BL. The extracellular matrix in oral squamous cell carcinoma: friend or foe? Head Neck. 2006;28(8):740-749.
46. Weber F, Xu Y, Zhang L, et al. Microenvironmental genomic alterations and clinicopathological behavior in head and neck squamous cell carcinoma. JAMA. 2007;297(2):187-195.